ACNAccenture
- Next report
- Dec 17
- Thursday, in 35 days · time not announced yet
- EPS expected
- $3.90
- quarter ending Nov 30, 2026
- Last result
- $3.80Beat
- vs $3.68 expected on Jun 18
- Stock move on it
- −17.97%
- one session
- Price
- $250.02
- −1.43% today · $86.2B cap
Past and upcoming reports
2
| Dec 17, 2026 | Nov 30, 2026 | Time not announced yet | $3.90 | not yet | |
| Jun 18, 2026 | May 31, 2026 | Before the market opens | $3.68 | Beat$3.80 | −17.97% |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 18, 2026 report
Accenture beats EPS estimates by 2.5% but shares plunge nearly 18% on growth concerns
Accenture reported Q3 EPS of $3.80 versus $3.71 estimate, a 2.5% beat, yet shares fell 17.97% amid weak revenue growth worries and oversold technicals. Despite strong valuation and quality metrics, market skepticism on growth persists.
Reported against expected
BeatReported EPS of $3.80 beat consensus estimate of $3.71 by 2.5%.
Guidance
No explicit guidance update provided. growth metrics remain below sector averages.
How the stock reacted
Shares dropped 17.97% on heavy volume following earnings beat, reflecting market concerns.
What changed
EPS beat estimates by 2.5%, but shares declined 18% due to growth concerns and oversold conditions.
What the price now assumes
Market is pricing in skepticism on Accenture's growth prospects, shown by sharp share decline and oversold RSI.
What it means for the business
Investors should remain cautious. watch for revenue growth improvement or margin guidance to reconsider upgrade.
The next one to three months, as we saw it then
Better case25%
Revenue growth accelerates above sector average, validating valuation and driving share recovery.
Base case50%
Steady but below-sector growth continues with stable margins, maintaining current valuation discount.
Worse case25%
Growth disappoints further, leading to continued share price weakness and valuation multiple contraction.
If you hold it
Hold unless next quarter's revenue growth falls below 5% or margins deteriorate significantly.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.